Skip to main content

Table 5 Comparison of planar-based whole-body (T1/2, WB) and SPECT-based abdominal effective half-lives (T1/2, SPECT) for Lu-177-PSMA-617 and Lu-177-Octreotate therapy

From: Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

Patient

T1/2, WB [h]

T1/2, SPECT [h]

Octreotate

 P1

40

53

 P2

43

61

 P3

43

56

 P4

52

73

 P5

62

87

 Median

43

61

PSMA-617

 P6

22

33

 P7

31

50

 P8

65

67

 P9

39

31

 P10

29

42

 Median

31

42